MariMed Q1 Revenue Increases 230% to $24.6 Million

MariMed Q1 2021 Results Reflect Highest Core Cannabis Revenue and Profitability Core Cannabis Revenue Increased 230% to $24.6m, EBITDA Increased 764% to $7.6m Q1 2021 vs. Q1 2020 Significantly Strengthened Balance Sheet and Improved Liquidity to Support Future Growth Conference Call to be Held on May 18th at 9:00 a.m. EDT NORWOOD, Mass., May 17, […]